FULL TEST
TEST BANK FOR PHARMACOTHERAPEUTICS FOR
ADVANCED PRACTICE A PRACTICAL APPROACH 5TH
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
| | | | | |
For |more |Test |banks, |ATI, |HES! |exams, |and |more |contact |us.
, Tableofcontent
| |
Chapter | I | Issues |for |the |Practitioner |in |Drug |Therapy
Chapter |2 |Pharmacokinetic |Basis |of |Therapeutics |and |Pharmacodynamic |Principles
|Chapter |3 | Impact |of |Drug |Interactions | and |Adverse |Events | on |Therapeutics
|Chapter |4 |Principles |of |Pharmacotherapy |in |Pediatrics, |Pregnancy, |and |Lactation
|Chapter |5 |Pharmacotherapy |Principles |in |Older |Adults
Chapter |6 |Principles |of |Antimicrobial |Therapy |Chapter
|7 |Pharmacogenomies
Chapter |8 |The |Economics |of |Pharmacotherapeutics
|Chapter |9 |Pharmacotherapy |of |Pain |Management
Chapter |I0 |Pain |Management |in |Opioid |Use |Disorder |(OUD) |Patients
|Chapter |11 |Cannabis |and |Pain |Management
Chapter | 12 |Contact |Dermatitis
Chapter |13 |Fungal, |Viral, |and |Bacterial |Infections |of |the |Skin
|Chapter |14 |Psoriasis
Chapter |I5 |Acne |Vulgaris |and |Rosacea |Chapter
|16 |Ophthalmic |Disorders
Chapter |I7 |Otitis |Media |and |Otitis |Externa
|Chapter |I8 |Hypertension
Chapter | I9 | Hyperlipidemia
Chapter |20 |Chronic |Stable |Angina |and |Myocardial |Infarction
|Chapter |2I |Heart |Failure
Chapter |22 |Arrhythmias
Chapter |23 | Respiratory |Infections
Chapter |24 |Asthma |and |Chronic |Obstructive |Pulmonary |Disease |Chapter
|25 |Gastric, |Functional, |and |Inflammatory |Bowel |Disorders |Chapter |26
|Gastroesophageal |Reflux |Disease |and |Peptic |Ulcer |Disease |Chapter |27
|Liver |Diseases
Chapter |28 | Urinary |Tract |Infection
Chapter |29 |Prostatic |Disorders |and |Erectile |Dysfunction |Chapter
|30 |Overactive |Bladder
Chapter |3I |Sexually |Transmitted |Infections
|Chapter |32 |Osteoarthritis |and |Gout
|Chapter |33 |Osteoporosis
Chapter |34 |Rheumatoid |Arthritis
|Chapter |35 |Headaches
Chapter |36 |Seizure |Disorders
|Chapter |37 |Alzheimer's |Disease
| Chapter |38 | Parkinson's
| Disease
Chapter |39 |Major |Depressive |Disorder |and |Bipolar |Disorders
|Chapter |40 |Anxiety |Disorders
Chapter | 41 | Sleep | Disorders
Chapter |42 |Attention |Deficit |Hyperactivity |Disorder
|Chapter |43 |Substance |Use |Disorders
Chapter |44 |Diabetes | Mellitus
Chapter |45 | Thyroid | and | Parathyroid | Disorders
,Chapter 46 Allergies and Allergic Reactions
| | | | |
Chapter 47 Human Immunodeficiency Virus
| | | | |
Chapter 48 Organ Transplantation
| | | |
Chapter 49 Thromboembolic Disorders
| | |
Chapter 50 Anemias
| | |
Chapter 5l Immunizations
| |
Chapter 52 Smoking Cessation
| | | |
Chapter 53 Weight Loss
| | | |
Chapter 54 Contraception
| | |
Chapter 55 Menopause
| |
Chapter 56 Vaginitis
| |
, lOMoAR | cPSD|
| 21007614
lOMoAR | |
cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
| | | | | | | |
MULTIPLE |CHOICE
1. Nurse |practitioner |prescriptive |authority |is |regulated |by:
A. The |National |Council |of |State |Boards |of |Nursing
B. The |U.S. |Drug |Enforcement |Administration
C. The |State |Board |of |Nursing |for |each |state
D. The |State |Board |of |Pharmacy
ANS: | C PTS: | 1
2. Physician |Assistant |(PA) |prescriptive |authority |is |regulated |by:
A. The |National |Council |of |State |Boards |of |Nursing
B. The |U.S. |Drug |Enforcement |Administration
C. The |State |Board |of |Nursing
D. The |State |Board |of |Medical |Examiners
ANS: | D PTS: | 1
3. Clinical |judgment |in |prescribing |includes:
A. Factoring |in |the |cost |to |the |patient |of |the |medication |prescribed
B. Always |prescribing |the |newest |medication |available |for |the |disease |process
C. Handing |out |drug |samples |to |poor |patients
D. Prescribing |all |generic |medications |to |cut |costs
ANS: | A PTS: | 1
4. Criteria |for |choosing |an |effective |drug |for |a |disorder |include:
A. Asking |the |patient |what |drug |they |think |would |work |best |for |them
B. Consulting |nationally |recognized |guidelines |for |disease |management
C. Prescribing |medications |that |are |available |as |samples |before |writing |a |prescription
D. Following |U.S. |Drug |Enforcement |Administration |(DEA) |guidelines |for
prescribing
|
ANS: | B PTS: | 1
5. Nurse |practitioner |practice |may |thrive |under |health-care |reform |due |to:
A. The |demonstrated |ability |of |nurse |practitioners |to |control |costs |and |improve |patient
| outcomes
B. The |fact |that |nurse |practitioners |will |be |able |to |practice |independently
C. The |fact |that |nurse |practitioners |will |have |full |reimbursement |under |health-care
| reform
D. The |ability |to |shift |accountability |for |Medicaid |to |the |state |level
ANS: | A PTS: | 1
TEST BANK FOR PHARMACOTHERAPEUTICS FOR
ADVANCED PRACTICE A PRACTICAL APPROACH 5TH
EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
['LIZ)LI12%5IL!
[LI.GIL
Complete Test bank, All Chapters are included.
| | | | | |
For |more |Test |banks, |ATI, |HES! |exams, |and |more |contact |us.
, Tableofcontent
| |
Chapter | I | Issues |for |the |Practitioner |in |Drug |Therapy
Chapter |2 |Pharmacokinetic |Basis |of |Therapeutics |and |Pharmacodynamic |Principles
|Chapter |3 | Impact |of |Drug |Interactions | and |Adverse |Events | on |Therapeutics
|Chapter |4 |Principles |of |Pharmacotherapy |in |Pediatrics, |Pregnancy, |and |Lactation
|Chapter |5 |Pharmacotherapy |Principles |in |Older |Adults
Chapter |6 |Principles |of |Antimicrobial |Therapy |Chapter
|7 |Pharmacogenomies
Chapter |8 |The |Economics |of |Pharmacotherapeutics
|Chapter |9 |Pharmacotherapy |of |Pain |Management
Chapter |I0 |Pain |Management |in |Opioid |Use |Disorder |(OUD) |Patients
|Chapter |11 |Cannabis |and |Pain |Management
Chapter | 12 |Contact |Dermatitis
Chapter |13 |Fungal, |Viral, |and |Bacterial |Infections |of |the |Skin
|Chapter |14 |Psoriasis
Chapter |I5 |Acne |Vulgaris |and |Rosacea |Chapter
|16 |Ophthalmic |Disorders
Chapter |I7 |Otitis |Media |and |Otitis |Externa
|Chapter |I8 |Hypertension
Chapter | I9 | Hyperlipidemia
Chapter |20 |Chronic |Stable |Angina |and |Myocardial |Infarction
|Chapter |2I |Heart |Failure
Chapter |22 |Arrhythmias
Chapter |23 | Respiratory |Infections
Chapter |24 |Asthma |and |Chronic |Obstructive |Pulmonary |Disease |Chapter
|25 |Gastric, |Functional, |and |Inflammatory |Bowel |Disorders |Chapter |26
|Gastroesophageal |Reflux |Disease |and |Peptic |Ulcer |Disease |Chapter |27
|Liver |Diseases
Chapter |28 | Urinary |Tract |Infection
Chapter |29 |Prostatic |Disorders |and |Erectile |Dysfunction |Chapter
|30 |Overactive |Bladder
Chapter |3I |Sexually |Transmitted |Infections
|Chapter |32 |Osteoarthritis |and |Gout
|Chapter |33 |Osteoporosis
Chapter |34 |Rheumatoid |Arthritis
|Chapter |35 |Headaches
Chapter |36 |Seizure |Disorders
|Chapter |37 |Alzheimer's |Disease
| Chapter |38 | Parkinson's
| Disease
Chapter |39 |Major |Depressive |Disorder |and |Bipolar |Disorders
|Chapter |40 |Anxiety |Disorders
Chapter | 41 | Sleep | Disorders
Chapter |42 |Attention |Deficit |Hyperactivity |Disorder
|Chapter |43 |Substance |Use |Disorders
Chapter |44 |Diabetes | Mellitus
Chapter |45 | Thyroid | and | Parathyroid | Disorders
,Chapter 46 Allergies and Allergic Reactions
| | | | |
Chapter 47 Human Immunodeficiency Virus
| | | | |
Chapter 48 Organ Transplantation
| | | |
Chapter 49 Thromboembolic Disorders
| | |
Chapter 50 Anemias
| | |
Chapter 5l Immunizations
| |
Chapter 52 Smoking Cessation
| | | |
Chapter 53 Weight Loss
| | | |
Chapter 54 Contraception
| | |
Chapter 55 Menopause
| |
Chapter 56 Vaginitis
| |
, lOMoAR | cPSD|
| 21007614
lOMoAR | |
cPSD| 21007614
Chapter 1 Issues for the Practitioner in Drug Therapy
| | | | | | | |
MULTIPLE |CHOICE
1. Nurse |practitioner |prescriptive |authority |is |regulated |by:
A. The |National |Council |of |State |Boards |of |Nursing
B. The |U.S. |Drug |Enforcement |Administration
C. The |State |Board |of |Nursing |for |each |state
D. The |State |Board |of |Pharmacy
ANS: | C PTS: | 1
2. Physician |Assistant |(PA) |prescriptive |authority |is |regulated |by:
A. The |National |Council |of |State |Boards |of |Nursing
B. The |U.S. |Drug |Enforcement |Administration
C. The |State |Board |of |Nursing
D. The |State |Board |of |Medical |Examiners
ANS: | D PTS: | 1
3. Clinical |judgment |in |prescribing |includes:
A. Factoring |in |the |cost |to |the |patient |of |the |medication |prescribed
B. Always |prescribing |the |newest |medication |available |for |the |disease |process
C. Handing |out |drug |samples |to |poor |patients
D. Prescribing |all |generic |medications |to |cut |costs
ANS: | A PTS: | 1
4. Criteria |for |choosing |an |effective |drug |for |a |disorder |include:
A. Asking |the |patient |what |drug |they |think |would |work |best |for |them
B. Consulting |nationally |recognized |guidelines |for |disease |management
C. Prescribing |medications |that |are |available |as |samples |before |writing |a |prescription
D. Following |U.S. |Drug |Enforcement |Administration |(DEA) |guidelines |for
prescribing
|
ANS: | B PTS: | 1
5. Nurse |practitioner |practice |may |thrive |under |health-care |reform |due |to:
A. The |demonstrated |ability |of |nurse |practitioners |to |control |costs |and |improve |patient
| outcomes
B. The |fact |that |nurse |practitioners |will |be |able |to |practice |independently
C. The |fact |that |nurse |practitioners |will |have |full |reimbursement |under |health-care
| reform
D. The |ability |to |shift |accountability |for |Medicaid |to |the |state |level
ANS: | A PTS: | 1